As “the old joke” has it, “an emerging market is one from which investors cannot emerge unscathed when things go wrong”, says Russ Mould of AJ Bell. Yet with commodity prices rallying and talk everywhere of a global upswing, today investors are more interested in what can go right.
Two-thirds of fund managers surveyed by Bank of America think emerging markets will be the best-performing major asset class this year, notes Jonathan Wheatley in the Financial Times. Around $17bn of overseas cash poured into 30 major developing countries during the first three weeks of January alone. Global investors had already ploughed nearly $180bn into emerging market stocks and bonds during the final quarter of last year. The MSCI Emerging Markets (EM) index has returned 83.7% since 23 March last year.
A structural growth story
Long the preserve of stodgy commodity exporters and metal bashers, today developing markets are no longer simply geared plays on the global growth cycle. There is plenty of structural growth potential too, with an increasingly dynamic tech scene. By next year “three times as many internet users will live in emerging markets” as in developed ones, says Mark Atherton in The Times. Investors in this category could do with a break. The MSCI EM index has returned 49% over the past decade, far short of the 156% gain on the equivalent developed-market index. The EM index finally regained its 2007 all-time high last month.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
On a longer view, emerging markets still beat the MSCI World index, says Ben Johnson on Morningstar.com. For all their “gut wrenching volatility” and prolonged slumps, since 2001 the EM index has returned an annualised 9.59% compared to 6.02% for developed markets.
These days emerging and developed markets are moving in increasingly tight lockstep anyway. That is not a good thing – global investors want diversification, not pale imitations of what happens on Wall Street. Policy announcements by the Federal Reserve can dictate trading movements from Sao Paulo to Mumbai. The key culprit appears to be the US dollar, which is widely thought to be heading lower.
As Graham Smith points out on fidelity.co.uk, a weaker dollar acts like a monetary stimulus for businesses in emerging economies, which often borrow in greenbacks. It also incentivises investment inflows from foreign buyers looking to diversify their currency exposure.
On around 15 times 2021 earnings, emerging markets are not especially cheap compared to their own history, but they offer better value than richly priced developed markets. After such prolonged gloom, investors think 2021 could prove “the year for emerging markets”.
-
Review: Trasierra – a yoga retreat in the Spanish hillsFlora Connell joins a yoga retreat at Trasierra, in the Sierra Morena mountains north of Seville
-
How much should I have in emergency savings?When your boiler breaks or your car won’t start, you can find yourself paying a hefty bill. How much should you have in emergency savings to cover unexpected costs?
-
Why CEOs deserve a pay riseOpinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
-
Rolls-Royce stock jumps 15% – could it climb further?Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
-
The power of private marketsInterview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseasesVertex Pharmaceuticals operates in a profitable subsector and is poised for further success
-
Global investors have overlooked these top tips in emerging marketsOpinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
-
King Coal has not been dethroned yet — should you buy?The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
-
It’s time to start buying Europe again, says Merryn Somerset WebbOpinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fadesFood-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
